Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole
申请人:Wyeth
公开号:US20030100579A1
公开(公告)日:2003-05-29
Compounds of the formula
1
useful for the treatment of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse and related illnesses.
Process for producing optically active chroman derivative and intermediate
申请人:Mitsuda Masaru
公开号:US20050014818A1
公开(公告)日:2005-01-20
A process for easily producing various optically active chroman derivatives that are useful as pharmaceutical intermediates from inexpensive starting materials is provided.
Cyclic hemiacetal (1) obtained from dihydrocoumarin through one step is asymmetrically reduced to produce an optically active halohydrin derivative (3), and the optically active halohydrin derivative (3) is cyclized to produce an optically active chroman derivative (13):
Triazaspirodecanon-Methyl-Chromane zur Bekämpfung von Erkrankungen des Zentralnervensystems
申请人:BAYER AG
公开号:EP0539803A1
公开(公告)日:1993-05-05
Triazaspirodecanon-methylchromane der allgemeinen Formel (I) werden hergestellt, indem man Methylchromane, die an der Methylgruppe durch entsprechende Abgangsgruppen substituiert sind mit Triazaspirodecanonen umsetzt. Die Stoffe können zur Herstellung von Arzneimitteln eingesetzt werden, insbesondere für Arzneimittel zur Bekämpfung von Erkrankungen des Zentralnervensystems.
Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
申请人:BAYER AG
公开号:EP0546388A1
公开(公告)日:1993-06-16
Azaheterocyclylmethyl-chromane werden hergestellt durch Umsetzung von entsprechenden Methylchromanen mit entsprechenden Azaheterocyclen, gegebenenfalls mit anschließender Variation der Substituenten. Die Azaheterocyclylmethyl-chromanekönnen als Wirkstoffe in Arzneimitteln, insbesondere zur Behandlung von Erkrankungen des Zentralnervensystems eingesetzt werden.
PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMAN DERIVATIVE AND INTERMEDIATE
申请人:KANEKA CORPORATION
公开号:EP1445324A1
公开(公告)日:2004-08-11
A process for easily producing various optically active chroman derivatives that are useful as pharmaceutical intermediates from inexpensive starting materials is provided.
Cyclic hemiacetal (1) obtained from dihydrocoumarin through one step is asymmetrically reduced to produce an optically active halohydrin derivative (3), and the optically active halohydrin derivative (3) is cyclized to produce an optically active chroman derivative (13):